SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Tularik Inc. (TLRK)
An SI Board Since October 1999
Posts SubjectMarks Bans Symbol
598 27 0 TLRK
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
248Anything is possible when greed is involved, but the open interest on the calls tom pope-6/21/2002
247<i>>>My question...... what does the fund manager gain, all fronts aCzechsinthemail-6/21/2002
246Tularik receives new Buy recommendation from Wachovia Securities: biz.yahoo.comCzechsinthemail-6/21/2002
245A couple of interesting links regarding blockbuster drugs and IP: Message 17627Czechsinthemail-6/20/2002
244Alas, poor Tularik! I knew him, Horatio. Some disappointment with today's Czechsinthemail-6/19/2002
243<i>Biotechs should have fewer problems from negative earnings surprises<tom pope-6/19/2002
242>>The slowest of the slow, handing off to those who will be regarded with Czechsinthemail-6/19/2002
241It's "pass the baton" days here, window dressing at the end of thescaram(o)uche-6/19/2002
240Good questions. I know that fund management companies have their own portfoliosCzechsinthemail-6/19/2002
239>> pre-arranged trades << It goes on and on. A fund manager allowsscaram(o)uche-6/19/2002
238Interesting to see the contrast of very high volume yesterday with very light voCzechsinthemail-6/19/2002
237the blocks today..... A good understanding of what happened in the sector, scaram(o)uche-6/18/2002
236From GS Report: TLRK discussed plans to 1)discontinue development of T611 for cmopgcw-6/17/2002
235<<Not a negative take, but company did not really take on the T67 bear casMiljenko Zuanic-6/16/2002
234NOVEL RECEPTORS Patent Number: WO0242458 Publication date: 2002-05-30 Invescaram(o)uche-6/14/2002
233United States Patent Application 20020052474 Kind Code A1 Shu, Hong-Bing ; scaram(o)uche-6/14/2002
232PPARg. They have 2 classes. Both show in models they effect glucose levels comkeokalani'nui-6/14/2002
231more from Protherics, nothing here to chew on, but the paper itself is probably scaram(o)uche-6/14/2002
230<<With about a million cases of HCC per year, it could be very big.>>rkrw-6/14/2002
229Improvement over dox seems like a reasonable expectation either as improved effiCzechsinthemail-6/14/2002
228Not a negative take, but company did not really take on the T67 bear case. The keokalani'nui-6/14/2002
227Wilder, The discussion of the preclinical candidates did sound very sexy, and tCzechsinthemail-6/14/2002
226Thanks for the heads up on insider buying. The recent buying between Goeddel anCzechsinthemail-6/13/2002
225Goeddel buys another 10K on open market, 10K shares, 5/21 to 5/30. That's tscaram(o)uche-6/13/2002
224The gs tlrk presentation was not convincing on T67, but the peek at the preclinikeokalani'nui-6/13/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News